Cercar
01/01/2024
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study
Durán-Martínez, M, Azriel, S, Doulatram-Gamgaram, VK, Moreno-Pérez, O, Pines-Corrales, PJ, Tejera-Pérez, C, Merino-Torres, JF, Brito-Sanfiel, M, Chico, A, Marco, A, García-Fernández, E, Martínez-Montoro, JI. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study. DIABETES & METABOLISM. 2024; 50(1)DOI:10.1016/j.diabet.2023.101501. PMID:38061425. IF:4.700(Q1/3D).
01/12/2023
Is the Spanish type 1 diabetes mellitus registry really necessary?
Escalada J., Pérez A., Rica I.. Is the Spanish type 1 diabetes mellitus registry really necessary?. Endocrinologia Diabetes y Nutricion. 2023; 70(10)DOI:10.1016/j.endinu.2023.05.002. PMID:38000969. IF:1.800(Q3/8D).
01/12/2023
Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects
López-Yerena, A, Padro, T, Villaplana, VD, Muñoz-García, N, Pérez, A, Vilahur, G, Badimon, L. Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects. Nutrients. 2023; 15(24)DOI:10.3390/nu15245084. PMID:38140343. IF:4.800(Q1/2D).
01/12/2023
Pharmacological modulation of vascular ageing: A review from VascAgeNet
Roth, L, Dogan, S, Tuna, BG, Aranyi, T, Benitez, S, Borrell-Pages, M, Bozaykut, P, De Meyer, GRY, Duca, L, Durmus, N, Fonseca, D, Fraenkel, E, Gillery, P, Giudici, A, Jaisson, S, Johansson, M, Julve, J, Lucas-Herald, AK, Martinet, W, Maurice, P, McDonnell, BJ, Ozbek, EN, Pucci, G, Pugh, CJA, Rochfort, KD, Roks, AJM, Rotllan, N, Shadiow, J, Sohrabi, Y, Spronck, B, Szeri, F, Terentes-Printzios, D, Aydin, ET, Tura-Ceide, O, Ucar, E, Yetik-Anacak, G. Pharmacological modulation of vascular ageing: A review from VascAgeNet. AGEING RESEARCH REVIEWS. 2023; 92DOI:10.1016/j.arr.2023.102122. PMID:37956927. IF:12.500(Q1/1D).
30/11/2023
Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes
Frontino, G, Succurro, E, Corcoy, R, Scialabba, F, Poloniato, A, Scavini, M. Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1270472. PMID:38098867. IF:3.900(Q2/3D).
22/11/2023
Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review
Pérez, A, Redondo-Antón, J, Romera, I, Lizán, L, Santos, MRD, Díaz-Cerezo, S, Orozco-Beltran, D. Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review. Diabetes Therapy. 2023; DOI:10.1007/s13300-023-01503-4. PMID:37989829. IF:2.800(Q3/6D).
15/11/2023
Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves
Mauricio, D, Gratacòs, M, Franch-Nadal, J. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovascular Diabetology. 2023; 22(1)DOI:10.1186/s12933-023-02056-3. PMID:37968679. IF:8.500(Q1/1D).
10/08/2023
Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control
García E., Gil P., Miñambres I., Benitez-Amaro A., Rodríguez C., Claudi L., Julve J., Benitez S., Sánchez-Quesada J.L., Rives J., Garcia-Moll X., Vilades D., Perez A., Llorente-Cortes V.. Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1236487. PMID:37635956. IF:3.900(Q2/3D).